The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 31, 2020
Filed:
Jan. 10, 2018
Applicant:
Nodus Therapeutics, Menlo Park, CA (US);
Inventors:
Jennifer R. Cochran, Stanford, CA (US);
Karl Dane Wittrup, Boston, MA (US);
Assignee:
NODUS THERAPEUTICS, Menlo Park, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 38/20 (2006.01); C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); A61K 31/7088 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1774 (2013.01); A61K 31/7088 (2013.01); A61K 38/179 (2013.01); A61K 38/1777 (2013.01); A61K 38/2013 (2013.01); A61K 39/39558 (2013.01); A61K 47/68 (2017.08); A61K 47/6811 (2017.08); A61P 35/00 (2018.01); C07K 16/2803 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); C07K 16/2878 (2013.01); C07K 2319/30 (2013.01);
Abstract
The present invention provides a method of treating cancer with an integrin-binding-Fc fusion protein alone or in combination with IL-2 and/or an immune stimulant (i.e., an immune checkpoint stimulator), and/or an immune checkpoint inhibitor. The invention also provides composition for use in such methods.